ARK ETF TR - GENOMIC REV ETF (ARKG)

CUSIP: 00214Q302

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / GENOMIC REV ETF
Total 13F shares
21,070,311
Share change
+1,096,661
Total reported value
$605,869,850
Put/Call ratio
191%
Price per share
$28.76
Number of holders
278
Value change
+$29,425,107
Number of buys
87
Number of sells
139

Quarterly Holders Quick Answers

What is CUSIP 00214Q302?
CUSIP 00214Q302 identifies ARKG - ARK ETF TR - GENOMIC REV ETF in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q1 2024

As of 31 Mar 2024, ARK ETF TR - GENOMIC REV ETF (ARKG) was held by 278 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,070,311 shares. The largest 10 holders included Main Management ETF Advisors, LLC, BNP PARIBAS FINANCIAL MARKETS, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, UBS Group AG, JPMORGAN CHASE & CO, LPL Financial LLC, CITIGROUP INC, BANK OF AMERICA CORP /DE/, and STATE OF WISCONSIN INVESTMENT BOARD. This page lists 279 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.